curriculum vitae thomas a. moore, m.d. - fda.gov€¦ · 2 thomas a. moore, m.d page 2 of 17...

1

Last updated: 01 Jun 2018

CURRICULUM VITAE Thomas A. Moore, M.D.

Date and Place of Birth: Citizenship: USA Home Address: Office Address: Infectious Disease Consultants of Kansas

1100 N. Saint Francis, Suite 130 Wichita, KS 67214 Phone: 316-264-3505 Fax: 316-264-0908 Email: [email protected]

Licensure: Kansas, Active 12/07/1990- Louisiana, Active 09/01/2010- Louisiana Dept of Pharmacy 09/15/2010- DEA Active NPI Education: Undergraduate: Washington University; B.A. (Classics), B.A. (Biology) 1984 Graduate: The University of Kansas School of Medicine,

M.D. (interrupted for Post-Sophomore Fellowship) Basic 7/84-6/86

Post-Sophomore Fellowship in Pathology 7/86-6/87 Clinical 7/87-5/89

Postgraduate: Baylor College of Medicine Affiliated Hospitals, Houston, TX, Residency in Internal Medicine 1989-1992 Chief Medical Resident, The Methodist Hospital 7/92-12/92

National Institutes of Health, National Institute of Allergy and Infectious Diseases, Bethesda, MD Fellowship in Infectious Diseases 1993-1996

Professional Certification: National Board of Medical Examiners 1990 American Board of Internal Medicine, Internal Medicine 1992 Recertification 2002 Recertification 2012 American Board of Internal Medicine, Infectious Diseases 1996 Recertification 2002 American Society of Tropical Medicine and Hygiene, Certificate of Knowledge in Tropical Medicine and Travelers' Health 2000 International Society of Travel Medicine, Certificate in Travel Health 2003 Military Service:

Lieutenant Commander (O-4), United States Public Health Service Active Reserve 26Jun93-05Jun97

Lieutenant Commander (O-4), United States Public Health Service Inactive Reserve 06Jun97-present

2

Thomas A. Moore, M.D of 17 Academic Appointments: Baylor College of Medicine Affiliated Hospitals, Houston, TX

Instructor, General Medicine Section 7/1992-6/1993 National Institutes of Health, Clinical Center, Bethesda, MD Clinical Instructor, Infectious Disease Consult Service 7/1996-6/1997 University of Kansas School of Medicine-Wichita Campus, Wichita, KS Clinical Assistant Professor, Department of Medicine 10/1997-6/2004 Clinical Associate Professor, Department of Medicine 7/2004-6/2007 Clinical Professor, Department of Medicine 7/2007-8/2010 Associate Program Director for Internal Medicine 7/2005-6/2008 Subspecialty Education Coordinator, Infectious Disease Section 5/2007-6/2010 Committee Appointments DIME Committee 2005-2008

Visiting Professor Committee 2006-2010 Ochsner Health System, New Orleans, LA Chair, Department of Infectious Diseases 9/1/2010-8/31/2012 University of Kansas School of Medicine-Wichita Campus, Wichita, KS Clinical Professor of Medicine, Department of Medicine 9/1/2012-present Administrative Appointments: Via Christi Regional Medical Center, Wichita, Kansas Infection Control Committee 1998-2010 2012-present Pharmacy and Therapeutics Committee 1998-2010 2012-present Antibiotic Subcommittee 1998-2010 2012-present Microbiology Medical Advisory Committee 1998-2010 2012-present Wesley Medical Center, Wichita, Kansas Infection Control Committee 1998-2010 2012-present Pharmacy and Therapeutics Committee 1998-2010 2012-present Antibiotic Subcommittee 1998-2010 2012-present Medical Intensive Care Unit Committee 1999-2010 Laboratory Stewardship Committee 2017-present Chair, Medical Microbiology Advisory Committee 2016-present Director, Infection Control and Antibiotic Stewardship Programs 2016-present Select Specialty Hospital, Wichita, Kansas Chair, Infection Control Committee 2000-2010 Chair, Pharmacy and Therapeutics Committee 2000-2010 Vice President, Medical Staff 2000-2010 Kansas Heart Hospital, Wichita, Kansas Advisor, Infection Control Committee 2002-2010 Advisor, Infection Control Committee 2013-present The University of Kansas School of Medicine, Wichita, Kansas

Seymour Lectureship Committee 1998-2010 Chair 2006-2010 Internal Medicine Resident Competency and Selection Committee 2000-2010 Internal Review Panel, Family Medicine Sports Medicine Program 2005 University of Kansas MPH Program External Advisory Committee 2004 Director, Infection Control and Antibiotic Stewardship Programs, Kansas Surgery &

3

Recovery Center (KSARC) 2015-present Director, Infection Control and Antibiotic Stewardship Programs, Kansas Spine &

Specialty Hospital (KSSH) 2015-present Ochsner Medical Center, New Orleans, LA Pharmacy & Therapeutics Committee 2010-2012

4

Thomas A. Moore, M.D Page 3 of 17

Veterans' Administration Medical Center, Houston, Texas Ambulatory Care and Outpatient Clinic 6/1991-6/1993 Emergency Department 1/1993-6/1993

National Naval Medical Center, Bethesda, Maryland 6/1996-6/1997 Clinical Center, National Institutes of Health, Bethesda, Maryland 7/1996-6/1997 Via Christi Regional Medical Center, Wichita, Kansas; Active 1997-2010

2012-present Wesley Medical Center, Wichita, Kansas; Active 1997-2010

2012-present Riverside Hospital, Wichita, Kansas; Active 1997-6/2002 Kansas Surgery and Recovery Center, Wichita, Kansas; Active 1997-2010

2012-present Via Christi Rehabilitation Center-Our Lady of Lourdes Campus (courtesy) 1997-2010 Select Specialty Hospital, Wichita, Kansas; Active 1997-2010

2012-present Kansas Heart Hospital, Wichita, Kansas; Active 1997-2010

2012-present Galichia Heart Hospital, Wichita, Kansas; Active 2001-2010 Kansas Spine Hospital, Wichita, Kansas; Active 1997-2010

2012-present Robert J. Dole Veterans’ Administration Medical Center, Wichita, KS 2007-2010 Ochsner Foundation Hospital, New Orleans, LA 2010-2012 Medical Society Memberships: Greater Washington Infectious Disease Society (GWIDS) 1993-97 Washington Society for Helminthology 1994-97 Medical Society of Sedgwick County 1997-2010 2010-present Member, Public Health Committee 1998-2002 Member, Board of Directors 2014-2018 Member, Credentials Committee 2018- Kansas Medical Society 1997-2010 2010-present Louisiana-Mississippi Infectious Disease Society (LaMIDS) 2010-2012 Professional Organizations: American College of Physicians (ACP) 1989-present Status:

Associate 1989 Member 1993 Fellow 2002 Infectious Diseases Society of America (IDSA) 1993-present Status:

Associate 1993 Member 1996 Fellow 2010 Activities: Member, Clinical Affairs Committee 2002-2006 Member, Education Committee 2004-2006 Member, Clinical Practice Meeting Workgroup 2004-2006 Member, Annual Meeting Program Committee 2006-2009 Member, Publications Committee 2013-2016 Activities: IDSA representative to Consensus Guideline Workgroup

5

on Fecal Transplantation 2010-2011 Member, Board of Directors 2015-2018 Vice Chair, IDSA Foundation 2017-2018 IDSA representative to AGA Committee on Fecal

Microbiota Transplantation 2014-

6

Thomas A. Moore, M.D Page 4 of 17 Infectious Diseases Society of America (IDSA) (continued) Chair, IDSA Workforce Study Work Group 2016-2017 Board Liaison, Global Health Committee 2016-2018 International Society of Travel Medicine (ISTM), Member 1993-present American Society of Tropical Medicine and Hygiene (ASTMH) Member 1993-present

American Committee on Clinical Tropical Medicine and Travelers' Health 1993-present

American Society for Microbiology (ASM), Member 1995-2010 American Society of Transplantation (AST)

Member 1997-2007 Infectious Disease Community of Practice 1999-2009 The Transplantation Society, Infectious Disease Section, Member 1999-2007 International Society for Infectious Diseases (ISID), Member 2004-2006 Association of Program Directors in Internal Medicine (APDIM), Member 2005-2008 Honors and Awards:

Eagle Scout, Troop 542, Holy Cross Lutheran Church, Wichita, KS 1980 Thor J. Jager, M.D., Award for Distinguished Clinical Teaching 1999

Internal Medicine Residents’ Faculty Teaching Award 1999 “Dictator of the Year”, Wesley Medical Center Medical Transcription Service 2000

Alpha Omega Alpha Honor Society, Alumnus 2000 Doctoral Marshal, School of Medicine, University of Kansas Commencement 2001 Jayhawker, M.D. Medical Student Teaching Award 2002 “Wichita’s Top Doctors”, Wichita Register Magazine 2005 Commencement Speaker, Internal Medicine Resident Graduation Ceremony,

University of Kansas School of Medicine-Wichita 2005 Saint Luke Recognition Physician Award for Community Service,

Via Christi Health Network, Wichita, KS 2006 “Best Infectious Disease Physician in Wichita”; Wichita Magazine 2007 Best Doctors in America 2007- “Best Infectious Disease Physician in Kansas”; Wichita Business Journal 2010 “Best Doctors of New Orleans”, New Orleans Magazine 2011 2011 Teaching Award Nominee, University of Queensland Ochsner Clinical School 2011 Best Infectious Disease Physician; Wichita Business Journal 2013 Best Infectious Disease Physician; Wichita Business Journal 2015 Other Appointments/Professional Activities: GeoSentinel Pilot Project, Clinical Center, National Institutes of Health 1996-1997

Chairman, City-wide Infectious Disease Conference, Wichita, KS 1997-2010 Emerging Infections Network (joint project of CDC & IDSA) 1999- Chairman, 2000 "Drugs and Bugs" Symposium 2000

Ad hoc member, Grant Application Review Panel, Office of Orphan Products Development, Office of the Commissioner, Food and Drug Administration (FDA) Dec 2002 Jun 2006 KDHE Bioterrorism Focus Group, Hyatt Regency Wichita Jul 2003 IDSA Media Training 2017 Member, IDSA Clinical Affairs Committee Ad Hoc Panel to review CDC Draft

“Guidelines for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings 2004” Jul 2004

Member, IDSA Clinical Affairs Committee, Correct Coding Resources Workgroup 2006 Member, MSSC Public Health Subcommittee on the Influenza Vaccine Shortage Oct 2004

Infectious Disease Board Question Review, American Board of Internal Medicine 2004-2010 Manuscript Reviewer

7

The American Journal of Tropical Medicine and Hygiene 1998- Clinical Infectious Diseases 2001- Journal of Infectious Diseases 2001-

American Journal of Transplantation 2005- Infection Control and Healthcare Epidemiology 2005-

8

Thomas A. Moore, M.D. Page 5 of 17

Emerging Infectious Diseases 2006- Scandinavian Journal of Gastroenterology 2011- BioMed Central Immunology 2011-

Research Grant Referee, Health Care Efficiency Research Programme, Netherlands Organization for Health Research and Development (ZonMw) The Hague, Netherlands 2007

Moderator, Concurrent Scientific Session 3 (of 3), 2007 ACP Kansas Chapter Associates’ Scientific Session, Hyatt Hotel, Wichita, KS 2007

Moderator, Symposium on “Tropical Medicine: Emerging and Re-Emerging Diseases in the Americas” (Symposium #125), 45th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA 2007

Research Grant Referee, Centennial Award, American Society of Tropical Medicine and Hygiene 2007-2010

Moderator, Symposium on “Emerging Issues in Tropical Medicine (Session 77)”, 48th Annual ICAAC/IDSA 46th Annual Meeting, Washington, DC 2008

Chair, Anti-Infective Drugs Advisory Committee (AIDAC), Center for Drug Evaluation and Research (CDER), Food and Drug Administration (FDA) 2008-2012

Ad Hoc Member, AIDAC, CDER, FDA 2012- Ad Hoc Member, Nonprescription Drugs Advisory Committee, CDER, FDA 2014 Moderator, Symposium on “Treatment of Imported Malaria - Overview of the

Artemisinins”; IDSA 47th Annual Meeting, Philadelphia, PA 2009 Moderator, Symposium on “Emerging Tropical Diseases” IDSA 47th Annual Meeting, Philadelphia, PA 2009 Moderator, Symposium on “Neglected Tropical Diseases: Where Do We Stand Now?” IDSA 47th Annual Meeting, Philadelphia, PA 2009 Moderator, “Challenging Cases in Tropical Infectious Diseases” IDSA 47th Annual Meeting, Philadelphia, PA 2009 Testimony presented to the Presidential Commission for the Study of Bioethical Issues Re: Scientific, Medical, and Public Health Information to Facilitate

Decision-Making for Pediatric Research on Medical Countermeasures 2012 Abstract review committee member, IDSA 2014 Annual Meeting 2014

National Working Group on a Regulatory Framework for Microbiota Transplantation (IDSA representative); University of Maryland Francis King Carey School of Law, Baltimore, MD 2015-

Clinical Research Activities:

Domestic Local Subinvestigator; Cubist / LCD-DR-09-03: A Randomized, Double-Blinded,

Active-Controlled, Dose Ranging Study of CB-183,315 in Patients with Clostridium difficile Infection (2011)

Local Subinvestigator; Pfizer / A5951110: Prospective Study of Opthalmologic Function in Patients Receiving Linezolid for Two Months or Greater (2010-)

Local Subinvestigator; Astellas / WSA-CS-003: Open Label Study of Isavuconazole in the Treatment of Patients with Aspergillosis and Renal Impairment or of Patients with Invasive Fungal Disease Caused by Rare Molds, Yeasts or Dimorphic Fungi (2011-)

Local Subinvestigator; Astellas / WSA-CS-008: A Phase III, Double-Blind, Randomized Study to Evaluate The Safety And Efficacy Of Isavuconazole (BAL8557) versus a Caspofungin Followed by Voriconazole Regimen In the Treatment of Candidemia and Other Invasive Candida Infections (2010-)

Local Subinvestigator; Astellas / WSA-CS-004: A Phase III, Double Blind, Randomized Study to Evaluate Safety and Efficacy of BAL8557 versus Voriconazole for Primary Treatment

9

of Invasive Fungal Disease Caused by Aspergillus Species or Other Filamentous Fungi (2010-)

Local Subinvestigator; Dynavax / DV2-HBV-17: An Observer-Blinded, Randomized Study Comparing the Safety and Immunogenicity of HEPLISAV to Licensed Vaccine (Engerix-B) Among Adults (18 to 75 Years of Age) with Chronic Kidney Disease (CKD) (2010)

Local Subinvestigator; Hoffmann La-Roche / NV25118: A Randomized, Multicenter, Single- Blinded, Parallel Study of 100 mg and 200 mg Oseltamivir Administered Intravenously for the Treatment of Influenza in Patients Aged ≥ 13 Years (2010-)

10


Local Subinvestigator; ViroPharma / 20621-200: A Phase 2, Randomized, Double-Blind, Placebo- Controlled, Dose-Ranging Study to Assess the Safety and Efficacy of Non-Toxigenic Clostridium difficile (VP 20621) for the Prevention of Occurrence of Clostridium difficile Infection (CDI) in Adult Patients Previously Treated for CDI (2011-)

Local Subinvestigator; ViiV Healthcare / A4001095: A Multicenter, Randomized, Double-Blind, Comparative Trial of Maraviroc + Darunavir/Ritonavir versus Emtricitabine/Tenofovir + Darunavir/Ritonavir for the Treatment of Antiretroviral-Naïve HIV-Infected Patients with CCR5-Tropic HIV-1 (2011-)

Local Subinvestigator; Cubist / DAP-HEOR-10-06: A Randomized, Pragmatic Study to Evaluate Comparative Effectiveness, Inpatient Resource Utilization and Cost, and Safety of Daptomycin vs. Vancomycin in the Treatment of Patients with Complicated Skin and Skin Structure Infections Due to Suspected or Documented MRSA (2011-)

Local Subinvestigator; Innovative Biosensors / IBI-564: Evaluation of the BioFlash-Dx System for Rapid Detection of Methicillin Resistant Staphylococcus aureus (MRSA) (2011-)

Local Principal Investigator; A Phase 2, Multicenter, Randomized, Double-Blind, Comparative Study of the Safety and Efficacy of 2 Doses of Tigecycline versus Imipenem/Cilastatin for the Treatment of Subjects with Hospital-Acquired Pneumonia (Protocol 3074K6-2000-WW; IND 56,518); 2008-10

Thesis Supervisor; Protective Eyewear or Not: Revisiting the Incidence of Blood and Bodily Fluids on Protective Eyewear in Anesthesia; Mark Crim, Brian Tackitt, and Jenni Thimesch; Newman University, Wichita, KS; 2008-09

Local Principal Investigator; A Phase3, Randomized, Double-Blind, Comparative Study of Micafungin (FK463) Versus Caspofungin as Antifungal Treatment in Patients with Invasive Candidiasis and Candidemia (Protocol 03-0-192); 2004-06

National Subinvestigator, A Double-Blinded, Placebo-Controlled Trial of Alpha Interferon Therapy for West Nile Meningoencephalitis (Protocol WN-102) [FDA IND#11736]; 2004-2010

Local Principal Investigator, Outcomes of Patients Not Responding to Oral Macrolide or ß-lactam Therapy for the Treatment of Community-Acquired Pneumonia due to Streptococcus pneumoniae (HMR3647A6012); 2004

Local Principal Investigator, A Phase II, Randomized, Double-Blind, Multi-Center Clinical Trial Comparing Safety and Pharmacokinetics of Standard of Care plus either Aurexis or Placebo for the Treatment of Staphylococcus aureus Bacteremia (INH-AUR-002); 2004

Local Principal Investigator, A Phase I/II Randomized, Placebo-controlled Trial to Assess the Safety and Efficacy of Intravenous Immunoglobulin G (OmR-IgG-AMTM) Containing High Anti- West Nile Virus Antibody Titers in Patients With, or at High Risk for Progression to West Nile Virus (WNV) Encephalitis and/or Myelitis (CASG #210) (DMID #03-107); 2004-10

Local Principal Investigator, Investigation of the Natural History of West Nile Virus Infection in Patients with or at Risk for Progression to West Nile Virus Encephalitis and/or Myelitis (CASG#211) (DMID #03-114); 2004-10

National Subinvestigator, Protocol for Therapy of West Nile Virus Meningoencephalitis with Interferon -2b: A Randomized Unblinded Clinical Trial (FDA IND# 10027); 2003-04 (Oral presentation of results at 2004 ICAAC, Abstract# ICAAC04-A-1563-ASM)

Local Principal Investigator, H-400-009, The Safety, Tolerability, and Immunogenicity of ACAM2000 Smallpox Vaccine in Adults Without Previous Smallpox Vaccination. A Randomized, Double-Blind, Fixed Dose, Phase 3 Comparison Between ACAM2000 and Dryvax Smallpox Vaccines; 2003-04

Local Principal Investigator, H-400-012, The Safety, Tolerability, and Immunogenicity of ACAM2000 Smallpox Vaccine in Adults with Previous Smallpox Vaccination: A Randomized, Double-Blind, Fixed Dose, Phase Comparison between ACAM2000 and Dryvax Smallpox Vaccines; 2003-4

Local Principal Investigator, Administration of Drotrecogin-alfa (activated) in Early stage Severe Sepsis (ADDRESS); 2003-04

Principal Investigator, Assessment of Prevalence and Incidence of Symptomatic Neurocysticercosis in Kansas; 2000-05

11

Principal Investigator, Tularemia in Kansas: A 30-year Retrospective Review; 2002 Local Principal Investigator, Protocol P02095: Open-Label, Limited Access Protocol of

Posaconazole) in the Treatment of Invasive Fungal Infections; 2002-5 Local Principal Investigator, Protocol 843-038: A Compassionate Use Study of Pleconaril in the

Treatment of Severe Picornaviral Illness in Adults, Children, and Neonates; 2002 Local Principal Investigator, Protocol P00041: Open-Label Treatment Protocol for the Safety and

Efficacy of SCH 56592 (posaconazole) in the Treatment of Invasive Fungal Infections; 2001-2

12


Local Principal Investigator, Pfizer Protocol 150-606-5165: “An Open-Label, Non-Comparative

Protocol for the Emergency Use of Voriconazole (UK 109, 496) in Patients with Life- threatening, Invasive Mycoses Who Are Failing on Currently Available Antifungal Agents; 2000

Local Principal Investigator, A Multicenter, Investigator-Blinded, Randomized Study to Compare the Safety and Efficacy of IV Daptomycin with that of Vancomycin or a Semi-synthetic Penicillin in the Treatment of Complicated Bacterial Skin and Soft Tissue Infections Due to Gram-Positive Bacteria (DAP-SST9801); 2000

Local Principal Investigator, A Multicenter, Open-Label, Randomized Study to Compare the Safety and Efficacy of IV Daptomycin with that of Vancomycin or a Semi-synthetic Penicillin in the Treatment of Bacteremic Infections Due to Gram-positive Bacteria (DAP-BAC9803); 2000

Local Principal Investigator, A Multicenter, Open-Label, Non-comparative Study to Assess the Safety and Efficacy of IV Daptomycin in the Treatment of Hospitalized Subjects with Infections Due to Gram-positive Bacteria that are Resistant to Vancomycin, or Who Are Otherwise Refractory to, or Contraindicated for, Currently Available Therapy (DAP-RRC9804); 2000

Local Principal Investigator, Aronex Protocol #AR-95-41, 356-006: A Prospective Randomized, Double-Blind, Comparative Multicenter Study to Evaluate Efficacy and Safety of

NYOTRAN (Liposomal Nystatin) and Amphotericin B for Empiric Antifungal Treatment in Neutropenic Patients; 1999

Local Principal Investigator, Aronex Protocol #AR-95-41, 356-007: A Prospective, Randomized, Double-Blind, Comparative Multicenter Study to Evaluate Clinical Efficacy and Safety of

NYOTRAN (Liposomal Nystatin) and Fluconazole in the Treatment of Patients with Candidemia, 1999

Local Subinvestigator, JR-397: Open Study of Synercid (quinupristin/dalfopristin, RP59500) for Emergency Use (Infection Due to Resistant Bacteria, Treatment Failure, or in Treatment- Intolerant Patients); 1999

International Principal Investigator, Comparison of Coprodiagnosis Tests for Strongyloidiasis, Ecuador;

Apr 2000 Sub-Investigator, Intestinal Helminthiases and Response to Novel Enteric Cholera Vaccine,

Ecuador; Mar 1998 Volunteer Activities: Alumni and Parents Program, Washington University 1994-2002 Wichita Collegiate School Career-Mentor Program 1999-2010 Via Christi Transplant Support Group 1998-2003

Annual Celebrity & Chef Cook-Off Orpheum Theatre Benefit 2002-05 Co-Chair, Promise Campaign for Early Childhood, Wichita Collegiate School 2004-06 Co-Chair, Crystal Heart Gala, American Heart Association 2006-07 Moderator, “Avian Influenza”, Upper School Ethics Day, Wichita Collegiate School Oct 2007 Keynote speaker, Wichita Collegiate School Mentor Program Feb 2009 Boy Scouts of America Den Leader, Tiger Cubs, Pack 591, High Plains District, Quivira Council 2008-09 Assistant Den Leader, Wolves, Pack 591, High Plains District, Quivira Council 2009-10 Assistant Den Leader, Bears, Pack 434, Fleur-de-Lis District, SE LA Council 2010-11 Assistant Den Leader, Webelos, Pack 434, Fleur-de-Lis District, SE LA Council 2011-13 Explorer Post Leader, Ochsner Baptist Hospital 2012 Member, Event Committee, Golden Eagle Luncheon 2012 Leader, Boy Scout Troop 520, Quivira Council, Wichita, KS 2013-

Teaching Activities:

Didactic “Hope Floats: Fecal Microbiota Transplantation” Grand Rounds, Department of Internal Medicine,

13

University of Kansas School of Medicine, Kansas City, KS Aug 2014 “Tickborne Illnesses found in Louisiana” Internal Medicine Core Lecture Series, Monroe Hall, Ochsner Medical Center, New Orleans, LA Aug 2011 “Clinical Aspects of Basic Parasitology” Tulane University Tropical Medicine Core Lecture Series,

Tulane University Department of Tropical Medicine, New Orleans, LA Mar 2011 “Infective Endocarditis” Internal Medicine Core Lecture Series, Monroe Hall, Ochsner Medical

Center; New Orleans, LA Oct 2010

14

Thomas A. Moore, M.D. Page 8 of 17 “Basic Aspects of Infectious Diseases Encountered in Clinical Orthopedics” UKSM-W Orthopedic Surgery Lecture Series, VCRMC-St Francis, Wichita, KS Aug 2009

The Chicago Infectious Disease Board Review Course 2008 “Intestinal Nematodes/Tissue Nematodes/Trematodes & Cestodes/Protozoal Infections”,

Wyndham Hotel, Chicago, IL Sep 2008 The Chicago Infectious Disease Board Review Course 2007

“Intestinal Nematodes/Tissue Nematodes/Trematodes & Cestodes/Protozoal Infections”, Congress Plaza Hotel, Chicago, IL Sep 2007

Internal Medicine Core Curriculum-Infectious Disease Board Review Feb 2007


Radisson City Center, Chicago, IL Sep 2006 The Chicago Infectious Disease Board Review Course 2005 “Intestinal Nematodes/Tissue Nematodes/Trematodes & Cestodes/Protozoal Infections”, Radisson City Center, Chicago, IL Sep 2005


Radisson City Center, Chicago, IL Nov 2004 Health of the Public: Meningitis Outbreaks, UKSM-Wichita Campus Feb 2004 Health of the Public: West Nile Virus in Kansas 2003, UKSM-Wichita Campus Nov 2003 Internal Medicine Core Curriculum-Infectious Disease Section , UKSM-Wichita Campus Nov 2003 Guest Lecturer, Health of the Public Clerkship, UKSM-Wichita Campus Nov 2003 Internal Medicine Core Curriculum-Infectious Disease Section , UKSM-Wichita Campus Feb 2003


LeMeridien Hotel, Chicago, IL Oct 2002 Internal Medicine Core Curriculum-Infectious Disease Section , UKSM-Wichita Campus May 2002

The Chicago Infectious Disease Board Review Course 2001 “Intestinal Nematodes/Tissue Nematodes/Trematodes & Cestodes/Protozoal Infections” Holiday Inn City Centre Hotel, Chicago, IL Oct 2001

The Chicago Infectious Disease Board Review Course 2000 “Intestinal Nematodes/Tissue Nematodes/Trematodes & Cestodes/Protozoal Infections” Westin River North, Chicago, IL Oct 2000

Internal Medicine Core Curriculum-Infectious Disease Section , UKSM-Wichita Campus Nov 2000 Internal Medicine Resident Journal Club Nov 2000 Wesley Medical Center Biopsy Case Conference Nov 2000 Internal Medicine Journal Club Nov 2000 The Chicago Infectious Disease Board Review Course 1999

“Intestinal Nematodes/Tissue Nematodes/Trematodes & Cestodes/Protozoal Infections” Holiday Inn Mart Plaza, Chicago, IL Oct 1999

Internal Medicine Core Curriculum-Infectious Disease Section , UKSM-Wichita Campus 1999 The Chicago Infectious Disease Board Review Course 1998

“Intestinal Nematodes/Tissue Nematodes/Trematodes & Cestodes/Protozoal Infections” Holiday Inn Mart Plaza, Chicago, IL Oct 1998

Internal Medicine Core Curriculum-Infectious Disease Section , UKSM-Wichita Campus 1998 Internal Medicine Core Curriculum-Infectious Disease Section, UKSM-Wichita Campus 1997

The Chicago Infectious Disease Board Review Course 1997 “Intestinal Nematodes/Tissue Nematodes/Trematodes & Cestodes/Protozoal Infections” Holiday Inn Mart Plaza, Chicago, IL (Oct 1997)

City-wide Infectious Disease Conference (meets weekly) 1997-2010 Internal Medicine Morning Teaching Conference, Wesley Medical Center 1997-2010 Internal Medicine Morning Teaching Conference, Via Christi Regional

Medical Center-St. Francis Campus 1997-2010

15

Curricular Materials Development-National The Chicago Infectious Disease Board Review Course 1997-2008 “Intestinal Nematodes/Tissue Nematodes/Trematodes & Cestodes/Protozoal Infections”,

Chicago, IL (curriculum designed and updated annually)

16


INVITED VISITING PROFESSORSHIPS Visiting Clinical Professor, Division of Infectious Diseases, Department of Medicine,

Baylor College of Medicine, Houston, TX (Aug 1997) -“Strongyloidiasis” Morning Teaching Conference, VA Medical Center, Houston, TX -“Liver Flukes” Morning Teaching Conference, Ben Taub General Hospital, Houston, TX -“Lymphatic Filariasis” City-Wide Infectious Disease Conference, Houston, TX -“Accidental Tourists: Travel-Related Infections”, BCM Int Med Conference, Houston, TX

Visiting Clinical Professor, Department of Medicine, University of Western Australia, Perth, Australia (Feb 1997) -“Current Diagnosis and Treatment of Strongyloidiasis”, University of Western Australia,

Perth, Australia -“Overview of Helminth Zoonoses”, Internal Medicine Grand Rounds, Fremantle Hospital,

Fremantle, Australia Visiting Clinical Professor, Department of Medicine, University of Kansas School of Medicine-

Wichita Campus, Wichita, KS (Feb 25, 1994) -“Parasitic Causes of Infectious Diarrhea”, Department of Medicine Grand Rounds, Roberts

Amphitheater, UKSM-W, Wichita, KS

ORAL PRESENTATIONS

International Meetings “Back to the Future: Bacteriotherapy as Salvage Therapy for Clostridium difficile Infection”,

Annual Scientific Meeting, Australasian Society for Infectious Disease, Sunshine Coast, Queensland, Australia (April 2008)

“Bad Bugs, No Drugs: IDSA-supported Initiatives to Combat Resistant Organisms”, Annual Scientific Meeting, Australasian Society for Infectious Disease, Sunshine Coast, Queensland, Australia (April 2008)

National Meetings “Clinical Controversies: Should Fecal Microbiota Transplantation be used as first line therapy?” 2015 Annual Meeting, Infectious Diseases Society of America; San Diego, CA (Oct 2015) “Update on Management of Clostridium difficile”; 2015 Edith M. Hart Medical Staff Retreat;

John C. Lincoln Health Network; Loews Hotel, Santa Monica, CA (June 2015) “Fecal Microbiota Transplantation Update 2014”, APIC Annual Conference, Anaheim, CA

(Jun 2014) “Fecal Microbiota Transplantation Update”; National webinar for State Foundations for Medical

Care (Apr 2014) ‘Travel Medicine Update”, Vincent T. Andriole ID Board Review Course, 2013 Annual Meeting,

Infectious Diseases Society of America Annual Meeting, San Francisco, CA (Oct 2013) “Travel-related Diseases”, Vincent T. Andriole ID Board Review Course, 2012 Annual Meeting, Infectious Diseases Society of America Annual Meeting, San Diego, CA (Oct 2012) “Sepsis due to Vibrio infections”, Hospital Medicine Precourse, 2012 Annual Meeting,

American College of Physicians, New Orleans, LA (Apr 2012) “An Unusual Presentation of An Unusual Illness: Afebrile Familial Hibernian Fever”

N.D. Tofteland and T.A. Moore; Poster Finalist, Clinical Vignette Associate Member National Abstract Competition, 2010 Annual Meeting, American College of Physicians, Toronto, Ontario (April 2010)

“Hemolytic Anemia in Clostridium perfringens Bacteremia” C. Butler, T.A. Moore; Poster Finalist, Research

Associate Member National Abstract Competition, 2010 Annual Meeting, American College of Physicians, Toronto, Ontario (April 2010)

“Pneumonia due to Tsukamurella pulmonis—first report and review of the literature” R. Maalouf, T Moore; Associates Abstract Competition Presentation, 2008 Annual Meeting, American College of Physicians, Washington, DC (May 2008)

“Novel Therapies for Clostridium difficile disease” (Session #611), Symposium on “Clostridium

17

difficile: Current Epidemiology and Novel Therapies” (Symposium #71), 45th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA (Oct 2007)

“Update on Anti-helminthic Therapy” (Session #61), Symposium on “Antiparasitic Agents 2007” (Symposium #9), 45th Annual Meeting of the Infectious Diseases Society of America, San Diego, CA (Oct 2007)

18


“Hantavirus Pulmonary Syndrome: A Potential Role for Drotrecogin-alfa”

F. Bysfield, T. Moore; Associates Abstract Competition Presentation, 2006 ACP Annual Meeting, Philadelphia, PA (Apr 2006)

“Chronic Histoplasma Meningitis Refractory to Standard Therapy” J. Regier and T.A. Moore; Associates Abstract Competition Presentation,

2004 ACP Annual Meeting, New Orleans, LA (Apr 2004) "Molecular phylogenetic studies of members of the genus Strongyloides based on 5S ribosomal gene

sequences", 45th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Baltimore, MD (Nov 1996)

State/Regional/Community Kansas ACP Meeting “The Human Microbiome” 2017 Guest Faculty, 18th Annual Update in Infectious Diseases in Primary Care

Univiersity of Iowa, Iowa City, IA -“Tickborne Diseases” -Expert case presentation panel Hotel Vetro, Iowa City, IA 2016

“HCV Update”; 35th Annual Family Medicine Winter Symposium; Wichita Marriott Hotel, Wichita, KS (Dec 2015) “Microbiome Transplants: ONCtober Fest; Via Christi Cancer Institute; Wichita, KS (Oct 2015) “Should businesses require immunizations as a condition of employment?” Roundtable Discussion;

Wichita Business Coalition on Health Care; Wichita, KS (Oct 2014) “Infectious Disease Case Presentations ”; 2014 Annual Meeting, Alaska ACP/AKOMA; Millenium

Hotel, Anchorage, AK (May 2014) “Infectious Disease Update 2014”; 2014 Annual Meeting, Alaska ACP/AKOMA; Millenium Hotel,

Anchorage, AK (May 2014) “Antimicrobial Resistant Organisms in the Outpatient Setting” Central College Health Association

Annual Conference 2014, Manhattan, KS (March 2014) “Infections in the College Student” Central College Health Association Annual Conference 2014,

Manhattan, KS (March 2014) “Fecal Microbiota Transplantation”; Webinar for Kansas Foundation for Medical Care (Feb 2014)

“Infections in Wound Care”; 2014 Annual Meeting, Mid-America Wound Healing Society; Newman University, Wichita, KS (Apr 2014)

“New Bugs, New Drugs”, 12th Annual Southern Hospital Medicine Conference; InterContiental Hotel, New Orleans, LA (Oct 2011)

“Tropical Medicine Cases from Kansas” New Orleans City-Wide Infectious Disease Conference; Ochsner Medical Center, New Orleans, LA (Oct 29, 2010)

“Tropical Diseases in Kansas” Garden City Hospital Grand Rounds, Garden City, KS (Oct 2008) “Update on CA-MRSA and Cutaneous Manifestations of HIV, HCV, and Other Infections”

2008 Annual Meeting of the Kansas Dermatological Society, Hyatt Hotel, Wichita, KS (Aug 2008)

“Update on MRSA and Clostridium difficile” 2008 Annual Meeting, Kansas Academy of Physician Assistants, Hotel at Old Town, Wichita, KS (Jun 2008)

“Guidelines for Endocarditis Prophylaxis 2008: By The Skin of Our Teeth?” 19th Annual Symposium on the Medical Management of Cardiovascular Disease, University of Kansas School of Medicine-Wichita, Wichita, KS (May 2008)

“Breakfast with the Professor”, ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2007) “The New Faces of Old Bugs” 26th Annual Family Medicine Winter Symposium; University of

Kansas School of Medicine-Wichita, Wichita Marriott Hotel, Wichita, KS (Dec 2006) “Atypical Joint Infections” 37th Annual Symposium for Health Professionals; Arthritis Foundation,

Kansas Chapter, Airport Hilton, Wichita, KS (Oct 2006) “Infectious Disease Emergencies” Mount Carmel Regional Medical Center, Pittsburg, KS

(May 2006) “Infective Endocarditis 2006: Timing of Surgical Intervention” 17th Annual Symposium on the

19

Medical Management of Cardiovascular Disease, University of Kansas School of Medicine- Wichita, Wichita, KS (May 2006)

Visiting Clinical Professor, Division of Infectious Diseases, Department of Medicine, University of Iowa, Iowa City, IA (Apr 2006)

20

Thomas A. Moore, M.D. Page 11 of 17 -“Infectious Disease Update 2006: Mumps and More” -“Exotic Bugs in Your Own Backyard” 8th Annual Update in Infectious Diseases: Infectious Diseases in Primary Care

Sheraton Iowa City Hotel, Iowa City, IA “Avian Influenza Update” Expert Roundtable, Medical Society of Sedgwick County General

Meeting, Wichita, KS (Feb 2006) “Community-Acquired MRSA: 2005 Update” Pediatrics Grand Rounds, Wesley Medical Center,

Wichita, KS (Oct 2005) “When I Was A Resident…” University of Kansas School of Medicine-Wichita Internal Medicine

Resident Commencement Address (Jun 2005) “2005 Infectious Disease Update” Kansas Association of Osteopathic Medicine Annual Meeting,

Marriott Hotel, Wichita, KS (Apr 2005) “2004 Update of Infections in Transplant Recipients: Rabies, West Nile Virus, Strongyloidiasis,

and Now the Influenza Vaccine Shortage”, United Network for Organ Sharing (UNOS) Regional Fall Forum, Airport Hilton, Kansas City, MO (Oct 2004)

“West Nile Virus: Review of 2003 Data & Update for 2004”, Grand Rounds, Garden City Medical Center, Garden City, KS (Sep 2004)

“West Nile Virus: Review of 2003 Data & Update for 2004”, Grand Rounds, Dodge City Medical Center, Dodge City, KS (Sep 2004) “West Nile Virus: Review of 2003 Data & Update for 2004”, Family Medicine Kansas 2004

Convention, University of Kansas School of Medicine-Wichita, Wichita, KS (Apr 2004) “Breakfast with the Professor”, ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2003) “Physician Prescribing Practices are Rendering Antibiotics Useless”, Regional American Osteopathic

Association Meeting, Via Christi Riverside Medical Center, Wichita, KS (Mar 2003) "'Exotic' Bugs in Your Own Backyard: Unusual Infections Found in Kansas" 22nd Annual Family

Practice Update, UKSM-W; Marriott Hotel, Wichita, KS (Dec 2002) “Adult Immunizations”, UKSM-W Mini-Med School, Wichita, KS (Feb 2002) “Breakfast with the Professor”, ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2003) “Physician Prescribing Practices are Rendering Antibiotics Useless”, Regional American Osteopathic

Association Meeting, Via Christi Riverside Medical Center, Wichita, KS (Mar 2003) "'Exotic' Bugs in Your Own Backyard: Unusual Infections Found in Kansas" 22nd Annual Family

Practice Update, UKSM-W; Marriott Hotel, Wichita, KS (Dec 2002) “Adult Immunizations”, UKSM-W Mini-Med School, Wichita, KS (Feb 2002) “Bioterrorism: Review and Update”, Grand Rounds, Department of Psychiatry,

University of Kansas School of Medicine-Wichita, Wichita, KS (Jan 2002) “Anthrax and Other Biological Weapons”, Junior League of Wichita, Wichita, KS (Nov 2001) “Parasitology Update for the Primary Care Physician”, 79th Annual Fall Clinical Conference,

Kansas City Southwest Clinical Society, Marriott Hotel, Overland Park, KS (Nov 2001) “Bioterrorism: Thinking the Unthinkable”, Central Plains Expo, Wichita Airport Hilton, Wichita, KS

(Oct 2001) “Parasitic Infections Recently Encountered in Kansas”, Central Plains Expo, Wichita Airport Hilton,

Wichita, KS (Oct 2001) “Avoiding Antibiotic Resistance 2001”, Neosho County Medical Society, Chanute, KS (Sep 2001) “Medicine for the Traveler: What Internists Should Know”, 2001 ACP-ASIM Kansas Chapter

Scientific Meeting, Wichita, KS (Sep 2001) “Case Studies in Clinical Microbiology”, Southwestern Association of Clinical Microbiology,

Wichita, KS (Sep 2001) “Antibiotic Resistance 2001”, Newton Medical Center, Newton, KS (Jun 2001) “Necrotizing Fasciitis”, Kansas Society for Clinical Laboratory Scientists Annual Meeting,

Wichita, KS (May 2001) “Antibiotic Resistance 2001”, Seward County Medical Society, Liberal, KS (Mar 2001) “Antibiotic Resistance 2001”, Saint Catherine Hospital Grand Rounds, Garden City, KS (Mar 2001) “Antibiotic Resistance 2001”, Pratt Regional Medical Center Grand Rounds, Pratt, KS (Mar 2001) “Antibiotic Resistance 2001”, Sumner Regional Medical Center, Wellington, KS (Feb 2001)

21

“Current Trends in Streptococcus pneumoniae Resistance”, Harvey County Medical Society, Newton, KS (Jan 2001)

22


“Avoiding Antibiotic Resistance”, Grand Rounds, Newman Memorial County Hospital,

Emporia, KS (Dec 2000) “Streptococcus pneumoniae Resistance: Current Trends”, Hillside Medical Office, Wichita, KS

(Aug 2000) “Hepatitis C: Recent Advances”; Labette County Medical Center, Parsons, KS (Aug 2000) “Streptococcus pneumoniae Resistance: Current Trends”, Grand Rounds, McConnell AFB,

Wichita, KS (Jul 2000) “Guidelines for Diagnosis and Treatment of Infectious Hepatitis”, Kansas Nurse Practitioners’

Conference 2000, Wichita Marriott, Wichita, KS (Jun 2000) “Streptococcus pneumoniae Resistance: Current Trends”, Kansas Nurse Practitioners’

Conference 2000, Wichita Marriott, Wichita, KS (Jun 2000) “Diagnosis and Treatment of Candidemia in the Critically Ill Patient”, Hyatt Hotel, Wichita, KS

(May 2000) “Infectious Diseases in the New Millennium”, Dameshek Symposium, Via Christi Medical Center-

St. Joseph Campus, Wichita, KS (May 2000) “Streptococcus pneumoniae: Past, Present, and Future” Mercy Regional Medical Center,

Manhattan, KS (Apr 2000) “Infectious Hepatitis: Review for the Primary Care Physician”, Riverside Health System

Grand Rounds (Apr 2000) “Advances in the Management of Hepatitis C”, Hepatitis Education Initiative, West Wichita

Family Physicians, Wichita, KS (Apr 2000) “Hepatitis A through E”, Sumner County Regional Medical Center, Wellington, KS (Mar 2000) “Community-Acquired Pneumonia”, Cowley County Medical Society Meeting,

Winfield, KS (Jan 2000)

“Avoiding Antibiotic Resistance”, 1999 Kansas Chapter Scientific Meeting, Regional American College of Physicians Meeting, Wichita, KS (Sep 1999)

“Avoiding Antibiotic Resistance” Pratt Regional Medical Center (Teleconference); Pratt, KS (Sept 1999)

“Infectious Disease Update 1999” Galichia Medical Research Institute Annual Medical Update, Hyatt Hotel, Wichita, KS (Apr 1999)

“Infectious Disease Update 1999” Sumner County Regional Medical Center, Wellington, KS (Feb 1999)

“Infectious Disease Update 1999” Newman Memorial County Hospital, Emporia, KS (Feb 1999) “Community-Acquired Pneumonia” Hays Country Club, Hays KS (Nov 1998)

“Health Issues of International Travel”, University of Kansas 7th Annual Infectious Diseases Course: Advances in the Clinical Management of Infectious Diseases; Business Technology Association Conference Center, Kansas City, MO (Oct 2, 1998)

“Infectious Disease Update 1998” McPherson Hospital, McPherson, KS (Sep 1998) “Infectious Disease Update 1998” Newton Medical Center, Newton, KS (Aug 1998) “Infectious Disease Update 1998” Harper County Hospital, Harper, KS (May 1998) “Infections from Blood Products” 27th Annual Dr. William Dameshek Symposium,

Leukemia Society of America (Apr 1998) “Hepatitis C: The Silent Epidemic” Galichia Research Institute 3rd Annual Wichita Medical

Symposium, Hyatt Hotel, Wichita, KS (Apr 1998) “What’s New in Infectious Diseases” 12th Annual Clinical Update, Via Christi Hospital System,

Aboard the Sun Princess, Ft. Lauderdale, FL (Jan 1998)

PUBLICATIONS

Journals Moore TA, Dembry LM, Saag MS. Sunday in the Park with Infectious Disease: Workforce Mismatch

in a Colorful Universe of Possibilities. Journal of Infectious Diseases 2017 Sep 15;216 (suppl 5):S581-S587.

Moore TA, Rodriguez A, Bakken JS. Fecal Microbiota Transplantation: A Practical Update for the Infectious Disease Specialist. Clinical Infectious Diseases 2014 Feb;58(4):541-5.

23


Yoder JS, Bourgeois SS, Roy SL, Moore TA, Visvesvara GS, Ratard RC, Hill, VR, et al. Primary amebic meningoencephalitis deaths associated with sinus irrigation using

contaminated tap water. Clinical Infectious Diseases (in press). Streit JA, Marano C, Beekmann SE, Polgreen PM, Moore TA, Brunette GW, Kozarsky PE.

Travel and tropical medicine practice among infectious disease practicioners. Journal of Travel Medicine 2012 Mar;19(2):92-5. Epub 2012 Feb 24. Bakken JS, Borody T, Brandt LJ, Brill JV, Demarco DC, Franzos MA, Kelly C, Khoruts A,

Louie T, Martinelli LP, Moore TA, Russell MD, Surawicz C. Treating Clostridium difficile Infection with Fecal Microbiota Transplantation. Clinical Gastroenterology and Hepatology 2011 Dec;9(12):1044-9. Epub 2011 Aug 24.

Maalouf R, Mierau SB, Moore TA, Kaul A. First case report of community-acquired pneumonia due to Tsukamurella pulmonis. Ann Intern Med 2009 Jan 20;150(2):147-8.

Khan, Z, Assi M, Moore TA. Recurrent epidural abscess caused by Propionibacterium acnes. Kansas Journal of Medicine 2009;2(4):92-95.

Mortada R, El Fakih R, Saliba W, and Moore TA. Skin Lesions in a Returning Traveler. Infectious Diseases in Clinical Practice 2009;17:108-110.

El Fakih RO, Moore TA, Assi M. Sinusitis and orbital cellulitis due to community-associated methicillin-resistant Staphylococcus aureus. Kansas Journal of Medicine 2008;1(4):85-8.

El Fakih RO, Moore TA, Mortada RA. The danger of diagnostic error: community-acquired MRSA or spider bite? Kansas Journal of Medicine 2008;1(4):81-4.

Wehbe E, Moore TA. Cold agglutinin-associated hemolytic anemia due to brucellosis: first case report. American Journal of Hematology 2008 Aug;83(8):685-6.

Restrepo A, Tobon A, Clark B, Graham DR, Corcoran G, Bradsher RW, Goldman M, Pankey G, Moore T, Negroni R, Graybill JR. Salvage treatment of histoplasmosis with posaconazole. Journal of Infection 2007 Apr;54(4):319-27 [Epub 2006 Jul 7].

Weems JJ, Steinberg JP, Filler S, Baddley JW, Corey GR, Sampathkumar P, Winston L, John JF, Kubin CJ, Talwani R, Moore TA, Hetherington S, Texter M, Wenzel E, Kelley VA, Fowler VG. A phase II, randomized, double-blind, multi-center study comparing safety and pharmacokinetics of tefibazumab to placebo for the treatment of Staphylococcus aureus bacteremia. Antimicrobial Agents and Chemotherapy 2006;50(8):2751-5.

Daniels T, Moore TA. Neurocysticercosis in Kansas. Annals of Internal Medicine 2006 Jan 17;144(2):150-2.

Nash TE, Ohl CA, Thomas E, Subramanian G, Keiser P, Moore TA. Treatment of patients with refractory giardiasis. Clinical Infectious Diseases 2001 Jul 1;33(1):22-8.

McCarthy J, Moore TA. Emerging helminth zoonoses. International Journal for Parasitology 2000 Nov 1;30(12-13):1351-60.

Moore TA, Nutman TB. Eosinophilia in the returning traveler. Infectious Disease Clinics of North America 1998;12(2):503-21.

Moore TA, Nash TE. Parasitic infections obtained from eating raw fish. Infections in Medicine 1997;14:231-8. Moore TA. Visceral leishmaniasis (letter). N Engl J Med 1997;336:965. Moore TA, Tuazon CU. When to hospitalize for pneumonia: weighing the risks of outpatient

versus inpatient treatment. Journal of Respiratory Diseases 1996;17:878-93. Moore TA, Reynolds JC, Kenney RT, Johnston W, and Nutman TB. Diethylcarbamazine-induced

reversal of early lymphatic dysfunction in a patient with bancroftian filariasis: assessment using lymphoscintigraphy. Clinical Infectious Diseases 1996;23:1007-11.

Moore TA, Ramachandran S, Gam AA, Neva FA, Lu W, Saunders L, Williams SA, Nutman TB. Identification of novel sequences and frequency of codon usage in Strongyloides stercoralis.

Molecular and Biochemical Parasitology 1996;79:243-8. Moore TA, Tuazon CU. Cryptosporidium parvum: a significant respiratory pathogen?

Journal of Respiratory Diseases 1996;17:558-9. Gibson MK, Moore TA. Tropical pyomyositis in a patient from St. Croix.

Journal of Travel Medicine 1995;2:101-102. Moore TA, Bressler P, and Mawhorter S. Tropical pulmonary eosinophilia in an immigrant from

24

Guyana. Journal of Travel Medicine 1995;2:48-9. Moore TA, Baig S and White AC. Malaria and arthropod-borne parasitic diseases. Seminars in Pediatric Infectious Diseases 1994;5:148-54.

25

Thomas A. Moore, M.D. Page 14 of 17 Moore TA, Tomayko JF, Wiermann AM, Rensimer ER, White AC. Imported malaria in the 1990s:

A report of 59 cases from Houston, Texas. Archives of Family Medicine 1994;3:130-6.

Book Chapters Moore TA. Tissue nematodes. In: Schlossberg D (ed.), Clinical Infectious Disease,

2nd edition 2015, pp. 1258-67. Cambridge University Press, New York, NY. Moore TA. Chapter e26. Pharmacology of Agents Used to Treat Parasitic Infections. In: Harrison’s Principles of Internal Medicine, 19th edition 2014. McCarthy JS, Moore TA. Agents Used to Treat Infections Due to Parasites and Pneumocystis.

In: Mandell GL, Bennett JE, Dolin R (eds.), Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 8th edition 2014, Chap. 42; pp. 519-27. Elsevier Churchill Livingstone, Philadelphia, PA.

Moore TA. Chapter e26. Pharmacology of Agents Used to Treat Parasitic Infections. In: Harrison’s Principles of Internal Medicine, 18th edition 2011, pp.

Moore TA. Chapter 208. Agents Used to Treat Parasitic Infections. In: Harrison’s Principles of Internal Medicine, 18th edition 2011, pp. 1675-1682. McGraw-Hill, New York, NY.

Moore TA, McCarthy JS. Chapter 113. Enterobiasis. In: Guerrant RL, Walker DH, Weller PF (eds.), Tropical Infectious Diseases: Principles Pathogens, and Practice, 3rd edition 2011, pp 788-790. Churchill Livingstone, Philadelphia, PA.

McCarthy JS, Moore TA. Chapter 109. Toxocariasis. In: Guerrant RL, Walker DH, Weller PF (eds.), Tropical Infectious Diseases: Principles Pathogens, and Practice, 3rd edition 2011, pp 763-767. Churchill Livingstone, Philadelphia, PA.

Moore TA. Chapter 197. Ivermectin. In: Grayson ML, Crowe SM, McCarthy JS, Mills J, Mouton JW, Norrby SR, Paterson DL, Pfaller MA (eds.), Kucer’s Use of Antibiotics, 6th edition 2010, pp 2254-2262. Oxford University Press, London, England, UK.

Moore TA. Chapter 44. Agents Used to Treat Infections Due to Parasites and Pneumocystis. In: Mandell GL, Bennett JE, Dolin R (eds.), Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases, 7th edition 2010, pp. 631-668. Elsevier Churchill Livingstone, Philadelphia, PA.

Moore TA. Chapter e17. Pharmacology of Agents Used to Treat Parasitic Infections. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL Loscalzo J (eds.), Harrison’s Principles of Internal Medicine, 17th edition 2008, pp. e119-e126. McGraw-Hill, New York, NY.

Moore TA. Chapter 201. Agents Used to Treat Parasitic Infections. In: Fauci AS, Braunwald E, Kasper DL, Hauser SL, Longo DL, Jameson JL, Loscalzo J (eds.), Harrison’s Principles of Internal Medicine, 17th edition 2008, pp. 1270-5. McGraw-Hill, New York, NY.

Moore TA. Chapter 194. Tissue nematodes. In: Schlossberg D (ed.), Clinical Infectious Disease, 1st edition 2008, pp. 1343-52. Cambridge University Press, New York, NY.

Moore TA, McCarthy JS. Chapter 103: Toxocariasis. In: Guerrant RL, Walker DH, Weller PF (eds.), Tropical Infectious Diseases: Principles, Pathogens, and Practice, 2nd edition 2005, pp.1209-16. Churchill Livingstone, Philadelphia, PA.

McCarthy JS, Moore TA. Chapter 107: Enterobiasis. In: Guerrant RL, Walker DH, Weller PF (eds.), Tropical Infectious Diseases: Principles, Pathogens, and Practice, 2nd edition 2005, pp.1248-51. Churchill Livingstone, Philadelphia, PA.

Moore TA, McCarthy JS. Benzimidazoles (Albendazole, Mebendazole, Thiabendazole, Triclabendazole). In: Yu VL, Edwards G, McKinnon PS, Peloquin CA, Morse G (eds.), Antimicrobial Therapy and Vaccines, 2nd ed. 2005, pp.1021-36. ESun Technologies, Pittsburgh, PA.

Moore TA. Chapter 193: Agents Used to Treat Infections Due to Parasites and Pneumocystis. In: Kasper DL, Braunwald E, Fauci A, Hauser S, Longo D, Jameson JL (eds), Harrison’s Principles of Internal Medicine, 16th edition 2004, pp. 1202-14. McGraw-Hill, New York, NY.

Moore TA. Chapter 212: Therapy for Parasitic Infections. In: Braunwald E, Fauci AS, Kasper DL, Hauser SL, Longo DL, Jameson JL (eds.), Harrison’s Principles of Internal

26

Medicine, 15th ed. 2001, pp. 1192-8. McGraw-Hill, New York, NY. Moore TA, Nash TE. Tissue nematodes. In: Current Therapy of Infectious Disease, pp. 660-5.

Schlossberg D., 2nd ed. 2000. Mosby-Year Book, St. Louis, MO. Moore TA, Nash TE. Tissue helminths. In: Current Therapy of Infectious Disease, pp. 550-6.

Schlossberg D., 1st ed. 1996. Mosby-Year Book, St. Louis, MO.

27


Oral Abstracts and Posters “Bringing Africa to Kansas” S. Haydoura, D. Saad, S. Orozco-Do, T. Moore; 2010 ACP Scientific Meeting of the Kansas Chapter of the American College of Physicians, Kansas City, KS (Sep 2010) “Hemolytic Anemia in Clostridium perfringens Bacteremia” C. Butler, T. Moore,

2009 ACP Scientific Meeting of the Kansas Chapter of the American College of Physicians, Wichita, KS (Sep 2009)

“An Unusual Presentation of an Unusual Illness: Afebrile Familial Hibernian Fever” N. Tofteland, T. Moore, 2009 ACP Scientific Meeting of the Kansas Chapter of the American College of Physicians, Wichita, KS (Sep 2009)

“Eosinophilic Gastroenteritis Presenting as Fever of Unknown Origin” S. Abou-Anton, T. Moore, 2008 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2008) “Disseminated Zygomycosis Mimicking Pulmonary-Renal Vasculitis: First Case Report” W. Saliba,

R. El-Fakih, T. Moore, and J. Moussa; 2008 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2008)

“Rhabdomyolysis: An Unusual Presentation of Tularemia” E. Wehbe, S. Abou-Anton, D. Abou-Jaoude, J. Moussa, and T. Moore; 2008 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2008)

“Yellow Fever Vaccine-Associated Encephalitis” D. Chandab, T. Moore; 2008 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2008)

“Nocardia Brain Abscesses Misdiagnosed and Treated as Metastatic Lung Cancer” P. Crawley, B. El-Haddad, T. Moore; 2008 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2008)

“Cellulitis due to Mycobacterium haemophilum: Infection with Fastidious Organism Results in Change of Laboratory Practice; M. Griffey, T. Moore, and K. Heady; 2008 ACP Kansas

Chapter Scientific Meeting, Wichita, KS (Sep 2008) “Q Fever in Western Kansas” S. Jackson, T. Moore; 2008 ACP Kansas Chapter Scientific Meeting,

Wichita, KS (Sep 2008) “Actinomycetoma of the Knee After a Bull Fight Injury: First Report and Identification with

Molecular Techniques.” D. Zayour, T. Moore; 2007 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2007)

“Herpes Simplex 2: An Uncommon Presentation of a Common STD” A. Mansour, T. Moore, 2007 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2007)

“How often do we miss Q fever?” Y. Yammine and T. Moore; 2007 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2007)

“Pneumonia due to Tsukamurella pulmonis—first report and review of the literature” R. Maalouf , T. Moore; 2007 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2007)

“Beyond the Redness: Relapsing Polychondritis” J. Gorcos, T. Moore, 2006 ACP Kansas Chapter Scientific Meeting, Kansas City, KS (Sep 2006)

“Emphysematous Pyelonephritis in a Young Non-Diabetic: Of Zebras and Unicorns” J. McReynolds, T. Moore, 2006 ACP Kansas Chapter Scientific Meeting, Kansas City, KS (Sep 2006)

“Use of Drotrecogin-alfa in Nonmenstrual Staphylococcal Toxic Shock Syndrome” Z. Khan, T. Moore, 2006 ACP Kansas Chapter Scientific Meeting, Kansas City, KS (Sep 2006)

“Coxsackie B Encephalitis: A Rare Disease in Adulthood” R. Khazen, T. Moore, 2006 ACP Kansas Chapter Scientific Meeting, Kansas City, KS (Sep 2006)

“Hantavirus Pulmonary Syndrome: A Potential Role for Drotrecogin-alfa”, F. Bysfield, T. Moore; 2005 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2005)

“Colon Cancer and Streptococcus bovis: What, Exactly, Is the Connection?” E. Brumfield, T. Moore; 2005 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2005)

“Sydenham’s Chorea: The Movie!”, H Reed, TA Moore; 2005 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2005)

“Why I Like Dogs: Neuroretinitis and Meningitis due to Bartonella henselae” H. Reed, T. Moore; 2005 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2005)

“Snatching Defeat from the Jaws of Victory: Fatal Bacterial Superinfections Following Successful

28

Treatment of Severe Falciparum Malaria”, M. VanCleave, T. Moore; 2005 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2005)

“That Darn Cat: Severe and Fatal Community-Acquired Pneumonia due to Pasteurella multocida”, M. Warner, T. Moore; 2005 ACP Kansas Chapter Scientific Meeting, Wichita, KS

(Sep 2005)

29


“Disseminated Histoplasmosis: An Emerging Problem with Use of Etanercept, A Tumor Necrosis

Factor- Antagonist”, R Sharma, T Moore; 2005 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2005)

“Acute Encephalitis Due to Mycoplasma pneumoniae”, B. Maalouf, T. Moore, 2005 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2005)

“Necrotizing Myositis: Early Diagnosis and Successful Treatment” S.H. Wiebe, T. A. Moore; ACP 2005 Annual Session, San Francisco, CA (Apr 2005)

“Posaconazole (POS) as Salvage Therapy for Invasive Fungal Infections (IFIs) Unresponsive to Voriconazole: a Case Series,” R. Herbrecht, K. Marr, A. Catanzaro, R. Greenberg, H. Tissot-Dupont, H. Gallais, T. Moore, G. Corcoran, L. Pedicone (Poster M-1044); 44th Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Washington, DC (Nov 2004)

“A Prospective Study of Skin Changes in Necrotizing Fasciitis: Peau d’orange Skin Is a Reliable Clinical Finding, Facilitates Early Diagnosis, and Indicates the Limit of Proximal Extension of the Infection”, T. A. Moore (Abstract#04-AB-2158-IDSA); 42nd Annual Meeting of the Infectious Diseases Society of America, Boston, MA (Oct 2004)

“Syphilis and FUO”, M. K. Shamseddin, T. A. Moore, and H.C. Goodpasture; 2004 ACP Kansas Chapter Scientific Meeting, Kansas City, KS (Sep 2004)

“Sydenham’s Chorea: The Movie!” H. Reed, T. A. Moore 2004 ACP Kansas Chapter Scientific Meeting, Kansas City, KS (Sep 2004)

“Necrotizing Myositis: Early Diagnosis and Successful Treatment” S. H. Wiebe, T. A. Moore; 2004 ACP Kansas Chapter Scientific Meeting, Kansas City, KS (Sep 2004)

“Thyroid Storm Presenting as Severe Liver Dysfunction”, S. B. Hachem, T. A. Moore; 2004 ACP Kansas Chapter Scientific Meeting, Kansas City, KS (Sep 2004)

“A New and Serious Complication of Tongue Piercing”, S. L. Custer, T. A. Moore; 2004 ACP Kansas Chapter Scientific Meeting, Kansas City, KS (Sep 2004)

“Obstacles to the Timely Diagnosis of Osteoarticular Sporotrichosis”, S. L. Custer, T. A. Moore; 2004 ACP Kansas Chapter Scientific Meeting, Kansas City, KS (Sep 2004)

“Efficacy of Posaconazole in the Treatment of Non-Cryptococcal Central Nervous System Fungal Infections”, R. Hare, M. Alexov, H. Al-Abdely, T. Moore, R. Herbrecht, M. Territo, C. Hardalo, P. Zakowski, A. Langston (Abstract P009); 10th Congress of the European Confederation of Medical Mycology; Wroclaw, Poland (Jun 2004)

“’Hot Tub Lung’: Hypersensitivity Pneumonitis due to Mycobacterium avium complex (MAC),” R.A. Wahab, R.W. Spann, T.A. Moore; 2004 ACP Annual Meeting; New Orleans, LA (Apr 2004)

“An Unusual Case of Hyperkalemia in a Lung Cancer Patient,” W.V. Fattig, L.R. Harstine, T. A. Moore; 2004 ACP Annual Meeting, New Orleans, LA (Apr 2004)

“Successful Treatment of Acute Pulmonary and Disseminated Histoplasmosis With Posaconazole” A. Restrepo, B. Clark, D. Graham, S. Greene, R. Hare, G. Corcoran, C. Hardalo, T. Moore, R. Negroni, J. Graybill (Abstract#M-973); 43rd Annual Interscience Conference on Antimicrobial Agents and Chemotherapy (ICAAC), Chicago, IL (Sept 2003)

“Chronic Histoplasma Meningitis Refractory to Standard Therapy” J. Regier and T.A. Moore 2003 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2003)

“Monolobar Caroli’s Disease” D. Ghannam, T.A. Moore, E. Zayat, and M. Pham 2003 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2003)

“’Hot Tub Lung’: Hypersensitivity Pneumonitis due to Mycobacterium avium complex (MAC),” R.A. Wahab, T.A. Moore; 2003 ACP Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2003)

“Neurocysticercosis in Kansas” T. Daniels, T.A. Moore, (Abstract #422, Poster session B) 51st Annual Meeting of the American Society of Tropical Medicine and Hygiene,

Denver, CO (Nov 2002) "Treatment of Refractory Clostridium difficile Diarrhea Using Fecal Enema", Jennifer A. Jackson

and T. A. Moore, M.D., 2002 Kansas Chapter Scientific Meeting, ACP-ASIM, Kansas City, KS (Sep 2002)

30

“Staphylococcal Pyomyositis Mimicking Ewing Sarcoma”, Chau-Thong Nguyen-Dang and T. A. Moore, M.D., 2002 Kansas Chapter Scientific Meeting, ACP-ASIM, Kansas City, KS (Sep 2002)

“Of Worms and Wheezes: Two Cases of Strongyloides Hyperinfection Syndrome”, Kelly Vuong, MD, T. A. Moore, MD, FACP, 2001 ACP-ASIM Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2001)

31


“The Forgotten Angina: Lemierre’s Syndrome”, Pavan Reddy, MD, and T. A. Moore, MD, FACP

2001 ACP-ASIM Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2001) “Central Line-Associated Septic Pulmonary Embolism”, Ranjini Rajeskaran, MD, and

T. A. Moore, MD, FACP, 2001 ACP-ASIM Kansas Chapter Scientific Meeting, Wichita, KS (Sep 2001)

“Neurocysticercosis: An Emerging Disease in Kansas”, Titus L. Daniels and T. A. Moore, M.D. 2000 Kansas Chapter Scientific Meeting, Regional American College of Physicians Meeting, Kansas City, KS (Sep 2000)

“The identification and characterization of a repeated Strongyloides stercoralis-specific sequence useful for molecular diagnosis”, J. Kubofcik, T. A. Moore, F. A. Neva, and T. B. Nutman 48th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Washington, DC (Nov 1999)

“Mycoplasma-induced Encephalopathy” R. Dickson, DO and T. A. Moore, MD 1999 Kansas Chapter Scientific Meeting, Regional American College of Physicians Meeting, Wichita, KS (Sep 1999)

“A Case of Mistaken Identity: Pancreatic Pseudocyst Masquerading as a Hydatid Cyst”, Doyle Detweiler, MD and T. A. Moore, MD; 1998 Kansas Chapter Scientific Meeting, Regional American College of Physicians Meeting, Kansas City, KS (Sep 1998)

“Invasive Aspergillosis of the Paranasal Sinuses in a Neutropenic Patient”, Tatiana Okolzina, MD and T. A. Moore, MD; 1998 Kansas Chapter Scientific Meeting, Regional American College of Physicians Meeting, Kansas City, KS (Sep 1998)

“CNS Histoplasmosis in an Immunocompetent Host”, Rahul Singh, MD and T. A. Moore, MD 1998 Kansas Chapter Scientific Meeting, Regional American College of Physicians Meeting, Kansas City, KS (Sep 1998)

“Nocardia Brain Abscess: Treatment Strategies and Factors Influencing Outcome”, Samer I. Renno, MD and T. A. Moore, MD 1998 Kansas Chapter Scientific Meeting, Regional American College of Physicians Meeting, Kansas City, KS (Sep 1998)

"Molecular phylogenetic studies of members of the genus Strongyloides based on 5S ribosomal gene sequences", 45th Annual Meeting of the American Society of Tropical Medicine and Hygiene, Baltimore, MD (Nov 1996)

"Identification of novel genes and frequency of codon usage in filariform and rhabditiform stages of Strongyloides stercoralis", 44th Annual Meeting of the American Society of Tropical Medicine and Hygiene, San Antonio, TX (Nov 1995)

"Imported Malaria in the 1990s: A report of 63 cases from Houston, Texas", 32nd Annual Meeting of the Infectious Diseases Society of America, New Orleans, LA (Sep 1993)

Other “What If That’s Not Really a Spider Bite?” Health Care Partners Magazine (Via Christi Physician

Newsletter); Sept-Oct 2005

curriculum vitae thomas a. moore, m.d. - fda.gov€¦ · 2 thomas a. moore, m.d page 2 of 17...

Documents